20 results
S-1/A
EX-10.3
IKNA
Ikena Oncology Inc
22 Mar 21
IPO registration (amended)
8:51am
classified as employees on the payroll records of the Company and each Designated Subsidiary are eligible to participate in any one or more of the Offerings … are not contemporaneously classified as employees of the Company or a Designated Subsidiary for purposes of the Company’s or applicable Designated Subsidiary’s payroll
S-1/A
EX-3.3
IKNA
Ikena Oncology Inc
22 Mar 21
IPO registration (amended)
8:51am
by the holders of any series of Undesignated Preferred Stock, shall be classified, with respect to the term for which they severally hold office
8-K
EX-3.1
IKNA
Ikena Oncology Inc
30 Mar 21
Departure of Directors or Certain Officers
12:00am
be elected by the holders of any series of Undesignated Preferred Stock, shall be classified, with respect to the term for which they severally hold office
10-K
2021 FY
IKNA
Ikena Oncology Inc
17 Mar 22
Annual report
6:31am
in this patient disappeared and the patient was classified as a complete responder, as illustrated in the figure below. This patient was on treatment for 22 months … classified for national security purposes, as well as certain products and technical data relating to those products. If we expand our presence outside
8-K
EX-2.1
vwitszwzqv7d199bz
7 Aug 23
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
8:02am
10-Q
bneovye6n
13 May 21
Quarterly report
4:15pm
S-1/A
wec95pdfi dzoowgm
22 Mar 21
IPO registration (amended)
8:51am
DRS
lb869c1d1w xxoikt8l4
8 Jan 21
Draft registration statement
12:00am
S-1
xjwig9wux zu1jq1o8
5 Mar 21
IPO registration
2:59pm
DRS/A
mkqlh piw0hexvt01
11 Feb 21
Draft registration statement (amended)
12:00am
424B4
eunclg
26 Mar 21
Prospectus supplement with pricing info
5:04pm
- Prev
- 1
- Next